Prevalence of mpox in Yenagoa local government area, Bayelsa state, Nigeria

Doris Atibinye Dotimi; Daniel Inebimowei Kakatei; Oyaba Diemebonso; Richman Godbless; Balafama Alex-Hart; Ebiakpor Bainkpo Agbedi; Francis A. Balogun

doi:10.18203/2394-6040.ijcmph20253668

Authors

Doris Atibinye Dotimi Department of Community Health, Bayelsa Medical University, Yenagoa, Bayelsa State, Nigeria
Daniel Inebimowei Kakatei Department of Community Health, Bayelsa Medical University, Yenagoa, Bayelsa State, Nigeria
Oyaba Diemebonso Disease surveillance office, Yenagoa Local Government Area, Bayelsa State, Nigeria
Richman Godbless Department of Community Health, Bayelsa Medical University, Yenagoa, Bayelsa State, Nigeria
Balafama Alex-Hart Department of Paediatrics, University of Port Harcourt Teaching Hospital, Rivers State, Nigeria
Ebiakpor Bainkpo Agbedi Bayelsa State Primary Health Care Board, Yenagoa, Bayelsa State, Nigeria
Francis A. Balogun Department of Community Health, Lead City University, Ibadan, Nigeria

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20253668

Keywords:

Yenagoa, Monkeypox, Prevalence, Epidemiology, Bayelsa State, Mpox

Abstract

Background: A retrospective descriptive epidemiological study analyzed the occurrence of monkeypox (mpox) in Yenagoa local government area (LGA) of Bayelsa state, Nigeria, from 2017 to 2023.

Methods: Data on all suspected and confirmed cases were obtained from the disease surveillance office and analyzed using descriptive statistics, with results presented in tables, frequencies, and percentages.

Results: Yenagoa was identified as a persistent mpox hotspot, with 82 confirmed cases among a population of 798,000, representing a low but continuous prevalence rate of 0.0103%. Annual fluctuations with occasional peaks, particularly in 2022, suggest ongoing localized outbreaks rather than widespread endemicity. Most cases occurred among males (63.8%) and young adults aged 21-40 years, indicating specific demographic vulnerability. The case fatality rate of 1.25% corresponds with the less virulent West African clade. Prevalence varied across wards, with Epie and Atissa showing the highest rates, indicating regional transmission foci. Close human contact emerged as the predominant risk factor, followed by zoonotic exposure.

Conclusions: Seasonal patterns, with peaks between September and October, and uneven spatial distribution highlight the need for enhanced local interventions. Public health recommendations include strengthening routine surveillance, prioritizing high-prevalence wards, improving public awareness and risk communication, implementing targeted vaccination campaigns where feasible, and improving case management and outbreak preparedness for seasonal peaks. The findings underscore the importance of sustained surveillance and community engagement to interrupt transmission and prevent future mpox outbreaks in Yenagoa LGA.

Metrics

Metrics Loading ...

References

World Health Organization (WHO). Increasing preparedness and prevention measures for Monkeypox. Available at: https://www.who.int/ indonesia/news/detail/05-06-2022-increasing-preparedness-and-prevention-measures-for-monkeypox. Accessed on 3 March 2025.

World Health Organization (WHO). Mpox: Fact sheets. Available at: https://www.who.int/news-room/fact-sheets/detail/mpox. Accessed on 3 March 2025.

Muhammad OS, Muhammad ZS, Isra MK, Muhammad AS, Adnan MS, Sultan AM. Rising epidemiological trends in prevalence and mortality of Mpox. Global insights and analysis. Saudi Med J. 2024;45(12):1334-9. DOI: https://doi.org/10.15537/smj.2024.45.12.20240720

World Health Organization (WHO). Mpox African Region. Available at: https://www.who.int/ emergencies/disease-outbreak-news/item/2024-DON528. Accessed on 4 March 2025.

WHO Africa. Sustaining mpox response in Africa as efforts begin bearing fruits. Regional Office for Africa. Available from: https://www.afro.who.int/ news/sustaining-mpox-response-africa-efforts-begin-bearing-fruit. Accessed on 4 March 2025.

World Health Organisation. WHO Director-General declares Mpox outbreak a public health emergency of international concern. Available at: https://www.who.int/news/item/14-08-2024-who-director-general-declares-mpox-outbreak-a-public-health-emergency-of-international-concern. Accessed on 4 March 2025.

World Health Organisation (WHO). Multi-country outbreak of Mpox. External Situation Report 35- 12 August 2024. Available at: https://www.who.int/ publications/m/item/multi-country-outbreak-of-mpox--external-situation-report-35--12-august-2024. Accessed on 5 March 2025.

Centre for Disease Control (CDC). About Monkeypox. Available at: https://www.cdc.gov/ monkeypox/index.html. Accessed on 5 March 2025.

Nigeria Centre for Disease Control (NCDC). Situation Report. Update on Monkeypox (MPx) in Nigeria. Available at: https://ncdc.gov.ng/diseases/ sitreps/?cat=8&name=An%20Update%20of%20Monkeypox%20Outbreak%20in%20Nigeria. Accessed on 5 March 2025.

Nigeria Centre for Disease Control (NCDC). National Monkeypox Public Health Response Guidelines 2019. Federal Ministry of Health. Available at: https://ncdc.gov.ng/themes/common/ docs/protocols/96_1577798337.pdf. Accessed on 29 April 2025.

Rahman MD. Understanding Mpox and its pandemic threats. Dhaka School of Economics. 2024.

Eko D, Abaye BB, Adeoye I, Dairo M, Fawole O, Walter A, et al. PA-328 Descriptive epidemiology of mpox outbreak in Bayelsa state, Nigeria. BMJ Glob Health. 2023;8. DOI: https://doi.org/10.1136/bmjgh-2023-EDC.163

Yenagoa Local Government Council (2024). Local communities. Available at: https://www.yenagoalgc. by.gov.ng/local-communitiy. Accessed on 27 July 2025.

Britannica. Yenagoa. Available at: https://www.britannica.com/place/Yenagoa. Accessed on 27 July 2025.

SCRIBD. Yenagoa: Location, Climate, and Ecology. Available from: https://www.scribd.com/ document/802572523/YENAGOA-L-G-A. Accessed on 27 July 2025.

Nigeria Center of Disease Control (2017). Press Release: Suspected monkeypox outbreak in Bayelsa State. Available from: https://ncdc.gov.ng/ news/104/press-release:-suspected-monkeypox-outbreak-in-bayelsa-state Accessed on 27 July 2025.

Yinka-Ogunleye A, Aruna O, Dalhat M, Ogoina D, McCollum A, Disu Y, et al. Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiological report. Lancet Infect Dis. 2019;19(8):872-9. DOI: https://doi.org/10.1016/S1473-3099(19)30294-4

Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, et al. The changing epidemiology of human monkeypox- a potential threat? A systematic review. PLoS Neglect Trop Dis. 2022;16(2):e0010141. DOI: https://doi.org/10.1371/journal.pntd.0010141

Cheuyem FZL, Zemsi A, Ndungo JH, Achangwa C, Takpando-le-grand DR, Goupeyou-Youmsi JM, et al. Mpox severity and mortality in the most endemic focus in Africa: a systematic review and meta-analysis (1970-2024). MedRxiv. 2025. DOI: https://doi.org/10.1101/2025.04.07.25325410

Ogoina D, Iroezindu M, James HI, Oladokun R, Yinka-Ogunleye A, Wakama P, et al. Clinical Course and Outcome of Human Monkeypox in Nigeria. Clin Infect Dis. 2020;71(8). DOI: https://doi.org/10.1093/cid/ciaa143

Alakunle E, Moens U, Nchinda G, Okeke MI. Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution. Viruses. 2020 Nov 5;12(11):1257.

NCDC. Situation Report: Updates on monkey pox. Available at: https://ftp.ncdc.gov.ng/themes/ common/files/sitreps/d0af93a95ce7987469b85b10446e191a.pdf. Accessed on 27 July 2025.

Alakunle E, Moens U, Nchinda G, Okeke MI. Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution. Viruses. 2020;12(11):1257. DOI: https://doi.org/10.3390/v12111257